Goldman Sachs Group Inc Repligen Corp Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Repligen Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 243,004 shares of RGEN stock, worth $30.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
243,004
Previous 301,435 19.38%
Holding current value
$30.3 Million
Previous $38 Million 4.83%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$119.79 - $167.35 $7 Million - $9.78 Million
-58,431 Reduced 19.38%
243,004 $36.2 Million
Q2 2024

Aug 13, 2024
BUY
$120.0 - $182.95 $7.57 Million - $11.5 Million
63,104 Added 26.48%
301,435 $38 Million
Q1 2024

May 15, 2024
SELL
$170.78 - $208.42 $4.29 Million - $5.24 Million
-25,143 Reduced 9.54%
238,331 $43.8 Million
Q4 2023

Feb 13, 2024
SELL
$114.17 - $185.35 $4.14 Million - $6.72 Million
-36,271 Reduced 12.1%
263,474 $47.4 Million
Q3 2023

May 14, 2024
BUY
$138.78 - $176.51 $5.03 Million - $6.4 Million
36,271 Added 13.77%
299,745 $47.7 Million
Q3 2023

Nov 14, 2023
BUY
$138.78 - $176.51 $9.51 Million - $12.1 Million
68,506 Added 29.63%
299,745 $47.7 Million
Q2 2023

May 14, 2024
SELL
$138.42 - $180.31 $2.27 Million - $2.96 Million
-16,408 Reduced 6.63%
231,239 $32.7 Million
Q2 2023

Aug 14, 2023
SELL
$138.42 - $180.31 $2.27 Million - $2.96 Million
-16,408 Reduced 6.63%
231,239 $32.7 Million
Q1 2023

May 14, 2024
SELL
$154.26 - $198.1 $17.2 Million - $22.1 Million
-111,377 Reduced 31.02%
247,647 $41.7 Million
Q1 2023

May 11, 2023
SELL
$154.26 - $198.1 $17.2 Million - $22.1 Million
-111,377 Reduced 31.02%
247,647 $41.7 Million
Q4 2022

May 14, 2024
BUY
$162.42 - $220.56 $359,760 - $488,540
2,215 Added 0.62%
359,024 $60.8 Million
Q4 2022

Feb 13, 2023
BUY
$162.42 - $220.56 $359,760 - $488,540
2,215 Added 0.62%
359,024 $60.8 Million
Q3 2022

May 14, 2024
SELL
$160.42 - $256.21 $8.46 Million - $13.5 Million
-52,709 Reduced 12.87%
356,809 $66.8 Million
Q3 2022

Nov 10, 2022
SELL
$160.42 - $256.21 $8.46 Million - $13.5 Million
-52,709 Reduced 12.87%
356,809 $66.8 Million
Q2 2022

May 14, 2024
BUY
$140.68 - $188.02 $20.5 Million - $27.5 Million
146,044 Added 55.43%
409,518 $66.5 Million
Q2 2022

Aug 15, 2022
BUY
$140.68 - $188.02 $2.19 Million - $2.93 Million
15,567 Added 3.95%
409,518 $66.5 Million
Q1 2022

May 16, 2022
BUY
$161.19 - $257.96 $974,715 - $1.56 Million
6,047 Added 1.56%
393,951 $74.1 Million
Q4 2021

Feb 14, 2022
BUY
$247.59 - $304.47 $7.85 Million - $9.66 Million
31,711 Added 8.9%
387,904 $103 Million
Q3 2021

Nov 10, 2021
BUY
$194.77 - $324.21 $69.4 Million - $115 Million
356,193 New
356,193 $103 Million

Others Institutions Holding RGEN

# of Institutions
487
Shares Held
54.4M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email